Suchergebnisse - "Dexamethasone"

PubPharm (140.276)

41

The potentiating effect of intravenous dexamethasone upon preemptive pudendal block analgesia for hypospadias surgery in children managed with Snodgrass technique : a randomized controlled study : Dexamethasone for pain management in children

enthalten in: BMC anesthesiology | 2024

von Khalifa, S. | Slimene, A. | Blaiti, H. | +5

42

Uterine infusion strategies for infertile patients with recurrent implantation failure : a systematic review and network meta-analysis

enthalten in: Reproductive biology and endocrinology : RB&E | 2024

von Xie, Q. | Quan, X. | Lan, Y. | +1

43

Evaluation of chemotherapy-induced nausea and vomiting in pediatric patients with high-grade glioma treated with lomustine—a case series

enthalten in: Supportive care in cancer | 2024

von Schellekens, K. | Hageman, S. | Haverkate, E. | +4

44

The potentiating effect of intravenous dexamethasone upon preemptive pudendal block analgesia for hypospadias surgery in children managed with Snodgrass technique: a randomized controlled study

enthalten in: BMC anesthesiology | 2024

von Khalifa, S. | Slimene, A. | Blaiti, H. | +5

45

Uterine infusion strategies for infertile patients with recurrent implantation failure: a systematic review and network meta-analysis

enthalten in: Reproductive biology and endocrinology | 2024

von Xie, Q. | Quan, X. | Lan, Y. | +1

46

Cardiovascular symptoms of PASC are associated with trace-level cytokines that affect the function of human pluripotent stem cell derived cardiomyocytes

enthalten in: bioRxiv.org | 2024

von Sinclair, J. | Vedelago, C. | Ryan, F. | +25

47

Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia : Phase II Study of the Hyper-CVAD Regimen in Sequential Combination With Blinatumomab With or Without Inotuzumab Ozogamicin as Frontline Therapy for Adults With B-Cell Lineage Acute Lymphocytic Leukemia

enthalten in: ClinicalTrials.gov | 2024

48

LCI-HEM-MYE-CRD-004 (MMRC-073 CARJAK): Study of CRD for Carfilzomib-Refractory Multiple Myeloma : LCI-HEM-MYE-CRD-004 (MMRC-073 CARJAK): Phase I/II Study of Carfilzomib, Ruxolitinib, and Low Dose Dexamethasone for Carfilzomib-Refractory Multiple Myeloma

enthalten in: ClinicalTrials.gov | 2024

49

TJ202 Combined With Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma : A Phase 2, Multi-center, Single-arm Study of TJ202 Combined With Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma Who Received at Least 2 Prior Lines of Treatment

enthalten in: ClinicalTrials.gov | 2024

50

TJ202, Lenalidomide and Dexamethasone vs. Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma : A Phase 3, Randomized, Open-label, Parallel-controlled, Multi-center Study Comparing TJ202, Lenalidomide and Dexamethasone vs. Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma Who Received at Least 1 Prior Line of Treatment

enthalten in: ClinicalTrials.gov | 2024